Sutro BiopharmaSTRO
那斯達克 · USD
0.81
0.00
(+0.58%)
收盤 08/02 03:57 (UTC+8)
盤後
0
0
(0%)
08/02 03:57 (UTC+8)
Sutro BiopharmaSTRO
0.81
0.00
(+0.58%)
財務數據
損益表
- 0.09
- 0.13
- 0.10
- 0.17
- 1.14
- 0.13
- 0.26
- 0.09
- 0.15
- 0.17
- -65.67
- 46.83
- -17.85
- 62.54
- 571.95
- -88.56
- 97.62
- -66.86
- 73.81
- 17.49
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 17,399 | 14,809 | 8,520 | 25,706 | 13,008 | 113,721 | 16,924 | 10,412 | 12,674 | 8,632 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 17,399 | 14,809 | 8,520 | 25,706 | - | 113,721 | 16,924 | 10,412 | 12,674 | 8,632 |
營業費用 | 85,913 | 80,067 | 76,439 | 74,391 | - | 70,569 | 60,938 | 56,591 | 54,911 | 57,854 |
研發費用 | 51,597 | 71,037 | 62,108 | 62,020 | 56,878 | 53,765 | 45,669 | 41,592 | 39,399 | 43,135 |
推銷及管理費用 | 13,273 | 9,030 | 14,331 | 12,371 | 12,721 | 16,804 | 15,269 | 14,999 | 15,512 | 14,719 |
非經常性項目費用 | 21,043 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -68,514 | -65,258 | -67,919 | -48,685 | -56,591 | 43,152 | -44,014 | -46,179 | -42,237 | -49,222 |
其他收入及費用 | 1,890 | 3,860 | 35,529 | 3,153 | 1,883 | 2,018 | 1,811 | -73 | 2,560 | 2,821 |
利息費用 | 9,344 | 8,690 | 7,910 | 7,286 | 7,184 | 6,192 | 5,936 | 442 | 2,986 | - |
稅前純益 | -75,968 | -70,088 | -48,787 | -44,331 | -58,213 | 46,872 | -47,445 | -38,373 | -49,655 | -34,594 |
所得稅 | - | 2,355 | - | 8 | - | 15,807 | 1,839 | 151 | 395 | - |
稅後純益 | -75,968 | -72,443 | -48,787 | -48,018 | -58,213 | 31,065 | -49,284 | -38,524 | -50,050 | -34,594 |
基本每股稅後盈餘(元) | -0.91 | -0.83 | -0.59 | -0.59 | -0.95 | - | -0.81 | -0.64 | -0.85 | -0.61 |
稀釋每股稅後盈餘(元) | -0.91 | -0.89 | -0.58 | -0.54 | -0.95 | 0.52 | -0.81 | -0.64 | -0.85 | -0.61 |
基本平均股數(千股) | 83106.00 | 82592.00 | 82043.00 | 81224.00 | 61457.00 | - | 60599.00 | 60339.00 | 58723.00 | 57089.00 |
稀釋平均股數(千股) | 83106.00 | 82592.00 | 82043.00 | 81224.00 | 61457.00 | - | 60599.00 | 60339.00 | 58723.00 | 57089.00 |
還原基本每股稅後盈餘(元) | -0.91 | -0.83 | -0.59 | -0.59 | -0.95 | - | -0.81 | -0.64 | -0.85 | -0.61 |
還原稀釋每股稅後盈餘(元) | -0.91 | -0.89 | -0.58 | -0.54 | -0.95 | 0.52 | -0.81 | -0.64 | -0.85 | -0.61 |
還原基本平均股數(千股) | 83,106 | 82,592 | 82,043 | 81,224 | 61,457 | - | 60,599 | 60,339 | 58,723 | 57,089 |
還原稀釋平均股數(千股) | 83,106 | 82,592 | 82,043 | 81,224 | 61,457 | - | 60,599 | 60,339 | 58,723 | 57,089 |
EBITDA(千元) | -65,840 | -61,069 | -41,775 | -41,761 | -51,924 | 51,742 | -42,164 | -38,042 | -46,840 | -33,876 |